Situation Analysis
People living with diabetes are increasingly turning to technology to manage their condition. Leading this revolution is U.S.-based, global med tech company Dexcom, which develops and manufactures continuous glucose monitoring (CGM) technology. This small wearable device tracks a user's glucose levels 24-hours a day, providing real-time data to patients and eliminating the need for painful fingerpricks that are often synonymous with diabetes management.
Our agency is consistently tasked with raising awareness and increasing adoption of CGM technology in the over 15 markets, all with a unique set of regulatory parameters and government funding. CGM technology takes a major...